Abstract
Maternal antibody against fetal platelet antigens inherited from the father is a cause of severe thrombocytopenia in the neonate. Most cases of neonatal alloimmune thrombocytopenia (NAIT) are associated with antibodies against the human platelet antigen 1a (HPA-1a). Treatment is usually focused on suppressing the maternal antibodies, but the optimal agents and doses …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
